Ordaos

New York, NY · Founded 2019 · Privately Held (backing)

Operator of a human-enabled machine-driven drug design company intended for biomedical research and drug discovery. Ordaos is based in New York, NY and was founded in 2019. Its last reported valuation was $110 million in Nov 2024. It has raised $24.5 million across 6 recorded rounds; the latest was a $337,705 seed round in Feb 2025.

Last reported valuation
$110.0M
Oct 2026
Priced at
—
Total raised
$24.5M
Last round
Seed Round
Feb 2025

Who backs Ordaos?

16 investors
InvestorType
StartX (US)Other
AWS StartupsOther
2468 VenturesVenture capital
IAG Capital PartnersVenture capital
SeedFolioVenture capital
BioAdvance Capital (Conshohocken)Venture capital
Middleland CapitalVenture capital
Banyan Pacific Capital (Hong Kong)Family office
Citta Capital—
Future Labs—
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Ordaos investors

16 investors are on record for Ordaos, including StartX (US), AWS Startups, 2468 Ventures and IAG Capital Partners. By type, the record holds 5 venture capital firms and 1 family office. The seed round in Feb 2025 drew 3 investors.

Free account
More of Ordaos with a free account
  • ·The complete investor list: 16 names
  • ·Watch Ordaos: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like Ordaos. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View